Researchers have identified two experimental medications that may be able to promote myelin repair in people with MS, a study ...

Researchers have identified two compounds capable of repairing the protective myelin sheath damaged by multiple sclerosis, a major advance toward reversing nerve injury rather than just slowing it.

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These ...

DelveInsight's“ Multiple Sclerosis Pipeline Insight 2025 ” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the ...

In a new study, researchers found that increased expression of gene PRDM1-S triggers loss of immune regulation in autoimmune conditions like multiple sclerosis (MS). The findings could pave the way ...

Sept 2 (Reuters) - Sanofi's (SASY.PA), opens new tab most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials to treat relapsing forms of the disease, but in a ...

An update from BioNxt Solutions ( ($TSE:BNXT) ) is now available. BioNxt Solutions Inc., a bioscience company specializing in innovative drug ...

The lab is using AI to analyze complex biomedical data to improve drug development for many diseases, including MS and ...

FRANKFURT, Jan 13 (Reuters) - Merck KGaA said on Tuesday it had bought the rights to develop and market an experimental multiple sclerosis (MS) drug from British biotech company Apitope, expanding its ...

May 30, 2025, is the 17 th annual World Multiple Sclerosis Day, a day when the global medical community focuses on those living with Multiple Sclerosis (MS), a complex and frequently misunderstood ...